Taysha Gene Therapies (TSHA) Earnings (2019 - 2026)
Taysha Gene Therapies (TSHA) earnings from Sep 30, 2019 to Mar 31, 2026. The TTM Taysha Gene Therapies (TSHA) earnings is -$130M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Taysha Gene Therapies (TSHA) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +49.69% |
| 3 Years TTM | -0.87% |
| 5 Years TTM | +8.44% |
| All Time TTM | +26.12% |
Annual Earnings change of Taysha Gene Therapies (TSHA)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$42M | -61.09% |
| 2025 | -$109M | +22.05% |
| 2024 | -$89M | -19.96% |
| 2023 | -$112M | -32.79% |
| 2022 | -$166M | -4.88% |
| 2021 | -$175M | +190.82% |
| 2020 | -$60M | +5306.31% |
| 2019 | -$1.11M | N/A |
Comparison Taysha Gene Therapies (TSHA) five years earnings CAGR with competitors
Taysha Gene Therapies (TSHA) five years earnings CAGR is 8.44%.